Description: Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.
Home Page: universalibogaine.com
815 8th Avenue SW
Calgary,
AB
T2P 3P2
Canada
Phone:
855-426-4246
Officers
| Name | Title |
|---|---|
| Mr. Nicholas Peter Karos | CEO, Director of Capital Markets & Director |
| Mr. Greg J. Leavens C.A., CPA | CFO & Corporate Secretary |
| Mr. Shayne Nyquvest | Co-Founder |
| Mr. Dugan Selkirk | Manager Communications & Investor Relations |
| Cathy Fernandes | VP of Marketing & VP of Communications |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.3234 |
| Price-to-Sales TTM: | 1.3413 |
| IPO Date: | |
| Fiscal Year End: | July |
| Full Time Employees: | 0 |